Related Experiment Video
Updated: May 29, 2026

A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
Published on: July 5, 2017
Keratoconus: an ocular manifestation of systemic immune dysregulation?
Burhan Başkan1, Yusuf Evcimen1
1Department of Ophthalmology, SBU Van Training and Research Hospital, Van, Turkey.
Insights
This study found a significant link between keratoconus and immune-mediated diseases like rheumatoid arthritis and asthma in Eastern Anatolia. These findings suggest a potential role for the immune system in keratoconus development.
Area of Science:
- Ophthalmology
- Immunology
- Epidemiology
Background:
- Keratoconus, a corneal ectatic disorder, is traditionally viewed as non-inflammatory.
- Emerging evidence suggests a potential role for immune system involvement in keratoconus pathogenesis.
- This study investigates the epidemiological connection between keratoconus and immune-mediated diseases.
Purpose of the Study:
- To evaluate the association between keratoconus and various immune-mediated diseases.
- To assess the prevalence of specific immune diseases in a keratoconus cohort compared to controls.
- To explore the relationship between keratoconus severity and immune disease prevalence.
Main Methods:
- Retrospective cohort study including 642 keratoconus patients and 2568 age-sex-matched controls.
- Prevalence of rheumatoid arthritis, ulcerative colitis, Crohn's disease, Hashimoto's thyroiditis, autoimmune hepatitis, asthma, allergic rhinitis, and atopic dermatitis was compared.
- Logistic regression analysis adjusted for age, sex, BMI, and smoking status, with Bonferroni correction applied.
Main Results:
- A higher prevalence of any immune-mediated disease was observed in keratoconus patients (38.6%) compared to controls (21.2%).
- Significant associations, post-Bonferroni correction, were found for rheumatoid arthritis, asthma, allergic rhinitis, and autoimmune hepatitis.
- Immune disease prevalence demonstrated an increase with keratoconus severity.
Conclusions:
- Strong epidemiological associations suggest immunological mechanisms may contribute to keratoconus pathogenesis.
- The study highlights potential links between keratoconus and specific immune-mediated conditions.
- Further prospective studies are required to establish causality and validate these associations.
Background:
Keratoconus is a corneal ectatic disorder traditionally considered non-inflammatory, but emerging evidence suggests immune system involvement. This study evaluates the epidemiological relationship between keratoconus and immune-mediated diseases in the Eastern Anatolian population.
Research Design And Methods:
In this retrospective cohort study, 642 patients diagnosed with keratoconus (2017-2025) and 2568 age-sex-matched controls were examined. Prevalence of rheumatoid arthritis, ulcerative colitis, Crohn's disease, Hashimoto's thyroiditis, autoimmune hepatitis, asthma, allergic rhinitis, and atopic dermatitis was compared. Logistic regression adjusted for age, sex, BMI, and smoking status. Bonferroni correction (p < 0.00625) and sensitivity analyses were applied.
Results:
Any immune-mediated disease was present in 38.6% of keratoconus patients versus 21.2% of controls (p < 0.001). After Bonferroni correction, significant associations remained for rheumatoid arthritis (aOR = 7.89, p = 0.003), asthma (aOR = 2.32, p < 0.001), allergic rhinitis (aOR = 1.58, p = 0.001), and autoimmune hepatitis (aOR = 6.12, p = 0.006). Immune disease prevalence increased with keratoconus severity.
Conclusions:
Strong epidemiological associations exist between keratoconus and several immune-mediated diseases, suggesting immunological mechanisms may play a role in pathogenesis. However, findings demonstrate associations rather than causality, and some associations did not withstand correction for multiple comparisons. Prospective validation is needed.
Related Concept Videos
Microbiome of the Eye
Glaucoma: Overview
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Photoreceptors and Visual Pathways
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Inflammation: Introduction
